Published in Gastroenterol Clin Biol on January 01, 1996
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. World J Gastroenterol (2015) 0.77
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology (1996) 2.61
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther (2014) 2.42
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut (2005) 2.33
The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther (2014) 2.09
Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87
Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79
Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 1.73
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut (1999) 1.56
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut (1997) 1.46
A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J (1992) 1.46
Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.45
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
Crohn's disease clinical course and severity in obese patients. Clin Nutr (2002) 1.40
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39
[Idiopathic portal hypertension associated with connective tissue disease similar to systemic lupus erythematosus]. Gastroenterol Clin Biol (1989) 1.39
Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol (2000) 1.36
Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology (1992) 1.32
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol (2001) 1.27
Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther (1999) 1.27
The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr (1997) 1.26
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol (1984) 1.25
Effects of appendicectomy on the course of ulcerative colitis. Gut (2002) 1.24
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease. Ann Intern Med (1986) 1.22
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology (1988) 1.21
Preparation of a DNA matrix via an electrochemically directed copolymerization of pyrrole and oligonucleotides bearing a pyrrole group. Nucleic Acids Res (1994) 1.19
A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol (1982) 1.17
Drug induced lymphocytic colitis. Gut (1994) 1.13
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort. Ann Surg Oncol (2014) 1.11
DNA probe and PCR-specific reaction for Lactobacillus plantarum. J Appl Microbiol (1997) 1.10
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Serological arguments for classifying Raynaud's phenomenon as idiopathic. J Rheumatol (1990) 1.08
Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunol (1991) 1.08
Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol (1999) 1.06
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine. Aliment Pharmacol Ther (2009) 1.04
[Inflammatory polyarthritis associated with villous atrophy of the small intestine. Study of 2 cases]. Rev Rhum Mal Osteoartic (1980) 1.04
Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma. Br J Haematol (1987) 1.03
Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther (2011) 1.03
Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology (1985) 1.03
Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet (1994) 1.02
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther (2005) 0.99
Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol (1998) 0.99
Si dios quiere: Hispanic families' experiences of caring for a seriously mentally ill family member. Cult Med Psychiatry (1992) 0.99
Role of the ileocecal valve and site of intestinal resection in malabsorption after extensive small bowel resection. Digestion (1978) 0.99
Classification of the sequelae of bowel resection for Crohn's disease. Br J Surg (1994) 0.97
Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther (1998) 0.97
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol (1996) 0.96
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol (1994) 0.96
Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol (2009) 0.96